ARMP / Armata Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Armata Pharmaceuticals, Inc.
US ˙ NYSEAM ˙ US04216R1023

Ações em Circulação 36,695,155 shares
Ações de Insider47,566,307 shares
Total de Insiders43
Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

0 ( )
6076 out of 10948

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

0.000% ( )
5990 out of 10786

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

Armata Pharmaceuticals, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão
Richard Bastiani Director - [D] 27,778 27,778
Igor Bilinsky Chief Operating Officer - [O] 0 0
Biogen Idec Ma Inc 10% Owner - [10%] 11,926,948 11,926,948
Biogen Inc. 10% Owner - [10%] 11,926,948 11,926,948
Jack L Bowman Director - [D] 10,500 10,500
Richard Bear 27,383
Deborah Birx Chief Executive Officer, Director - [D] [O] 212,458 212,458
Barrie J Phd Carter Executive Vice President - [O] 48,766 48,766
Jeremy Curnock Cook Director - [D] 411,105 411,105
Joseph Md Phd Davie Director - [D] 11,000 11,000
Louis Drapeau Director - [D] 10,000 10,000
Delta Dental Plan of Michigan, Inc. 10% Owner - [10%] 2,531,604 2,531,604
Delta Dental of Wisconsin, Inc. 10% Owner - [10%] 2,586,356 2,586,356
Corp Plc Elan 10% Owner - [10%] 11,626,282 11,626,282
Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão
Elan International Services Ltd 10% Owner - [10%] 11,626,282 11,626,282
Paul C Grint Chief Executive Officer, Director - [D] [O] 599 599
Roger Hawley Director - [D] 10,000 10,000
Jules Haimovitz 33,000
Corp Intrexon 10% Owner - [10%] 674,169 674,169
Innoviva Strategic Opportunities LLC Director, 10% Owner - [D] [10%] 16,365,969 16,365,969
Innoviva, Inc. Director, 10% Owner - [D] [10%] 16,365,969 16,365,969
Johnson Wendy S. Interim Chief Operating Office, Director - [D] [O] 1,000 1,000
Randal J Kirk 10% Owner - [10%] 674,169 674,169
Kirk Julian P. 16,200
Odysseas D Kostas 33,000
Robin Kramer 33,000
Pierre Kyme Chief Business Officer - [O] 9,461 9,461
Nelson L Levy Director - [D] 10,070 10,070
Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão
Steven Robert Martin Chief Financial Officer - [O] 3,760 3,760
Duane Alfred Morris VP of Operations - [O] 52,288 52,288
H Stewart Parker Director - [D] 27,778 27,778
Joseph M Patti 33,000
Michael S Perry Director - [D] 411,105 411,105
Todd Patrick Chief Executive Officer, Director - [D] [O] 408,172 408,172
Peterson Todd C. 33,000
David J Poston CFO & VP Finance - [O] 36,700 36,700
Holding Co Renaissance 10% Owner - [10%] 2,531,604 2,531,604
BG Susan Robinson President and CEO - [O] 66,915 66,915
Richard Rychlik Corporate Controller and PFO - [O] 10,000 10,000
Vijay B Samant 10,900
Michael Scott Salka Chief Executive Officer, Director - [D] [O] 11,200 11,200
Schlesinger Sarah J. 33,000
Brian Varnum President and CDO - [O] 64,324 64,324

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em ARMP / Armata Pharmaceuticals, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custo Dias até
Máx
Preço em
Máx
Lucro
Máximo ($)
Retorno Máximo (%)
2022-03-31 Innoviva, Inc. 5,385,208 5.0000 5,385,208 5.0000 26,926,040 4 5.4000 2,154,083 8.00
2022-02-09 Innoviva, Inc. 3,614,792 5.0000 3,614,792 5.0000 18,073,960
2021-10-29 Innoviva, Inc. 1,212,122 3.3000 1,212,122 3.3000 4,000,003
2021-03-17 Innoviva, Inc. 4,285,935 3.2500 4,285,935 3.2500 13,929,289
2021-01-26 Innoviva, Inc. 1,867,912 3.2500 1,867,912 3.2500 6,070,714

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em ARMP / Armata Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custo Dias até
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2016-12-29 KIRK RANDAL J 20,077 0.4500 20,077 0.4500 9,035 112
2016-12-29 KIRK RANDAL J 21,923 0.4500 21,923 0.4500 9,865
2016-12-28 KIRK RANDAL J 40,450 0.4700 40,450 0.4700 19,012
2016-12-28 KIRK RANDAL J 44,170 0.4700 44,170 0.4700 20,760
2016-12-27 KIRK RANDAL J 24,092 0.5100 24,092 0.5100 12,287
2016-12-27 KIRK RANDAL J 26,308 0.5100 26,308 0.5100 13,417
2005-07-26 BIOGEN INC. 2,500 0.8700 101 21.4600 2,175
2005-07-26 BIOGEN INC. 25,660 0.8600 1,040 21.2133 22,068
2005-07-26 BIOGEN INC. 11,200 0.8500 454 20.9667 9,520

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo
Data
Data da
Operação
Formulário Insider Ticker Título de Segurança Código 10b5-1 Direto Preço de Exercício
Preço Unitário
Preço por
Unidade
Unidades
Alteradas
Valor
Alterado (1K)
Opções
Restantes
Ações
Restantes
2026-03-17 2026-03-14 4 Kyme Pierre ARMP Common Stock F - Taxes D 10.5400 -1,030 -11 9,461
2026-03-17 2026-03-14 4 Birx Deborah ARMP Common Stock F - Taxes D 10.5400 -4,919 -52 212,458
2025-07-14 2025-07-10 4 Birx Deborah ARMP Common Stock F - Taxes D 2.2700 -13,637 -31 217,377
2025-04-25 2025-03-14 4 Kyme Pierre ARMP Common Stock F - Taxes D 1.9500 -1,027 -2 10,491
2025-04-25 2025-03-14 4 Birx Deborah ARMP Common Stock F - Taxes D 1.9500 -6,061 -12 231,014
2025-04-25 2024-07-10 4 Birx Deborah ARMP Common Stock F - Taxes D 2.6800 -22,925 -61 237,075
2025-04-25 3/A Kyme Pierre ARMP Common Stock D 1,518
2024-06-28 3 Kyme Pierre ARMP Common Stock D 10,000
2024-03-18 2024-03-14 4 Rychlik Richard ARMP Common Stock A - Award D 10,000 10,000
2024-03-18 2024-03-14 4 Birx Deborah ARMP Common Stock A - Award D 60,000 260,000
2023-12-26 2023-12-21 4 Birx Deborah ARMP Common Stock A - Award D 200,000 200,000
2022-04-15 2022-04-13 4 Peterson Todd C. ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Schlesinger Sarah J. ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Patrick Todd ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Kramer Robin ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Kostas Odysseas D ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 PATTI JOSEPH M ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Morris Duane Alfred ARMP Stock Options (Right to Buy) A - Award D 5.11 41,000 41,000
2022-04-15 2022-04-13 4 Haimovitz Jules ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Varnum Brian ARMP Stock Options (Right to Buy) A - Award D 5.11 240,000 240,000
2022-04-01 2022-03-31 4 Innoviva, Inc. See footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 5.00 5.0000 0 0 2,692,604
2022-04-01 2022-03-31 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 5.0000 5,385,208 26,926 16,365,969
2022-02-11 2022-02-09 4 Innoviva, Inc. See footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 5.00 5.0000 1,807,396 9,037 1,807,396
2022-02-11 2022-02-09 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 5.0000 3,614,792 18,074 10,980,761
2021-11-01 2021-10-29 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 3.3000 1,212,122 4,000 7,365,969
2021-08-03 2021-08-02 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3.82 125,000 125,000
2021-06-09 2021-06-07 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 Kramer Robin ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-04-05 2021-04-01 4 Haimovitz Jules ARMP Stock Option (Right to Buy) A - Award D 4.74 30,000 30,000
2021-03-26 2021-03-25 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 5.14 112,000 112,000
2021-03-26 2021-03-25 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 5.14 28,000 28,000
2021-03-26 2021-03-25 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 5.14 112,000 112,000
2021-03-26 2021-03-25 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 5.14 56,000 56,000
2021-03-17 2021-03-17 4 Innoviva, Inc. See Footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 3.25 3.2500 4,285,935 13,929 6,153,847
2021-03-17 2021-03-17 4 Innoviva, Inc. See Footnotes ARMP Common Stock P - Purchase I 3.2500 4,285,935 13,929 6,153,847
2021-01-28 2021-01-26 4 Innoviva, Inc. See Footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 3.25 3.2500 1,867,912 6,071 1,867,912
2021-01-28 2021-01-26 4 Innoviva, Inc. See Footnotes ARMP Common Stock P - Purchase I 3.2500 1,867,912 6,071 1,867,912
2020-12-09 2020-12-08 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 BASTIANI RICHARD ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Kramer Robin ARMP Stock Option (Right to Buy) A - Award D 3.15 30,000 30,000
2020-03-31 2020-03-27 4 Innoviva, Inc. ARMP Warrants to Acquire Common Stock P - Purchase D 2.87 2.8700 7,717,661 22,150 8,710,800
2020-03-31 2020-03-27 4 Innoviva, Inc. ARMP Common Stock P - Purchase D 2.8700 7,717,661 22,150 8,710,800
2020-02-14 2019-05-09 5 PERRY MICHAEL S ARMP Warrant to Purchase Common Stock J - Other I 0.32 12,065.4600 -46,666 -563,047 0
2020-02-14 2019-05-09 5 COOK JEREMY CURNOCK ARMP Warrant to Purchase Common Stock J - Other I 0.32 12,065.4600 -46,666 -563,047 0
2020-02-14 2020-02-12 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 4.17 27,383 27,383
2020-02-14 2020-02-12 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 4.17 27,383 27,383
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1,986,278
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1,986,278
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1,986,278
2019-10-15 2019-10-10 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 3.77 27,383 27,383
2019-05-24 2019-05-22 4 BASTIANI RICHARD ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 COOK JEREMY CURNOCK ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 PARKER H STEWART ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 PERRY MICHAEL S ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 3.15 149,362 149,362
2019-05-24 2019-05-22 4 Bear Richard ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 3.15 298,724 298,724
2019-05-24 2019-05-22 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 3.15 74,681 74,681
2019-05-24 2019-05-22 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3.15 298,724 298,724
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3,736,669
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2,586,356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3,736,669
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2,586,356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2,586,356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3,736,669
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-16 3 Varnum Brian ARMP Common Stock D 64,324
2019-05-16 3 Varnum Brian ARMP Common Stock D 64,324
2019-05-16 3 Varnum Brian ARMP Common Stock D 64,324
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52,288
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52,288
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52,288
2019-05-16 3 Patrick Todd ARMP Common Stock D 408,172
2019-05-16 3 Patrick Todd ARMP Common Stock D 408,172
2019-05-16 3 Patrick Todd ARMP Common Stock D 408,172
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27,778
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27,778
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27,778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27,778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27,778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27,778
2018-03-26 2018-03-22 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 1.1000 181,820 200 411,105
2018-03-26 2017-09-19 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 105,015 229,285
2018-03-26 2017-06-29 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 5,757 124,270
2018-03-26 2016-11-22 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 0.57 0.1000 46,666 5 46,666
2018-03-26 2016-11-22 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 7.4000 46,666 345 118,513
2018-03-26 2016-06-21 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 15,057 71,847
2018-03-26 2018-03-22 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 1.1000 181,820 200 411,105
2018-03-26 2017-09-19 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 105,015 229,285
2018-03-26 2017-06-29 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 5,757 124,270
2017-12-12 2017-12-08 4 GRINT PAUL C APHB Common Stock A - Award D 0.6200 599 0 599
2017-09-12 2017-09-07 4 PERRY MICHAEL S APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-12 2017-09-07 4 SAMANT VIJAY B APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-11 2017-09-07 4 DRAPEAU LOUIS APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-11 2017-09-07 4 Johnson Wendy S. APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-11 2017-09-07 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 0.91 285,113 285,113
2017-09-11 2017-09-07 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 0.91 190,076 190,076
2017-09-11 2017-09-07 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 0.91 139,000 139,000
2017-09-11 2017-09-07 4 COOK JEREMY CURNOCK APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-06-01 2017-05-30 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0.74 87,161 87,161
2017-04-04 2017-04-01 4 Salka Michael Scott APHB Stock Option (Right to Buy) A - Award D 0.43 214,214 214,214
2017-04-04 2017-04-01 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 0.43 161,290 161,290
2017-04-04 2017-04-01 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0.43 176,411 176,411
2017-01-31 3 BILINSKY IGOR APHB Common Stock D 0
2017-01-31 2017-01-30 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0.46 247,322 247,322
2016-12-29 2016-12-29 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0.4500 -20,077 -9 674,169
2016-12-29 2016-12-29 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0.4500 -21,923 -10 736,170
2016-12-29 2016-12-28 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0.4700 -40,450 -19 694,246
2016-12-29 2016-12-28 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0.4700 -44,170 -21 758,093
2016-12-29 2016-12-27 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0.5100 -24,092 -12 734,696
2016-12-29 2016-12-27 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0.5100 -26,308 -13 802,263
2016-12-13 2016-12-09 4 Salka Michael Scott APHB Common Stock A - Award D 0.3900 7,000 3 11,200
2016-12-13 2016-12-09 4 Martin Steven Robert APHB Common Stock A - Award D 0.3900 3,760 1 3,760
2016-11-16 2016-11-12 4 KIRK RANDAL J by NRM VII Holdings APHB Series B Preferred Stock C - Conversion I -2,142,857 0
2016-11-16 2016-11-12 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock C - Conversion I 428,571 828,571
2016-04-12 3/A COOK JEREMY CURNOCK APHB Common Stock I 120,000
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock A - Award I 4.05 35,714 35,714
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock D - Sale to Issuer I 7.00 -35,714 0
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Series B Convertible Preferred Stock C - Conversion I -1,040,753 0
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 4.05 0.0010 34,184 0 34,184
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Series B Convertible Preferred Stock P - Purchase I 0.8100 326,468 264 1,040,753
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 171,298 567,903
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Common Stock C - Conversion I 208,150 396,605
2016-04-12 2015-03-16 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 10.75 10.7500 17,114 184 17,114
2016-04-12 2015-03-16 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 8.2500 68,455 565 188,455
2016-01-20 3 Martin Steven Robert APHB Common Stock D 0
2016-01-20 2016-01-18 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 2.85 99,919 99,919
2015-11-09 2015-11-05 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 5.65 16,200 16,200
2015-11-09 2015-11-05 4 SAMANT VIJAY B APHB Stock Option (Right to Buy) A - Award D 5.65 16,200 16,200
2015-10-07 2015-10-05 4 Johnson Wendy S. APHB Common Stock P - Purchase D 4.4270 1,000 4 1,000
2015-10-07 2015-10-06 4 DRAPEAU LOUIS APHB Common Stock P - Purchase D 4.3900 10,000 44 10,000
2015-10-06 2015-10-05 4 Salka Michael Scott APHB Common Stock P - Purchase D 4.7500 4,200 20 4,200
2015-09-23 2015-09-21 4 Johnson Wendy S. APHB Stock Option (right to buy) A - Award D 6.38 16,200 16,200
2015-09-23 2015-09-21 4 PERRY MICHAEL S APHB Stock Option (right to buy) A - Award D 6.38 12,800 12,800
2015-09-23 2015-09-21 4 DRAPEAU LOUIS APHB Stock Option (right to buy) A - Award D 6.38 13,800 13,800
2015-09-23 2015-09-21 4 COOK JEREMY CURNOCK APHB Stock Option (right to buy) A - Award D 6.38 38,500 38,500
2015-09-23 2015-09-21 4 Kirk Julian P. APHB Option to Purchase Common Stock A - Award D 6.38 16,200 16,200
2015-09-10 2015-09-08 4 Johnson Wendy S. APHB Stock Option (right to buy) A - Award D 7.46 49,965 49,965
2015-08-06 2015-08-05 4 Salka Michael Scott APHB Stock Option (right to buy) A - Award D 0.19 19,985,810 19,985,810
2015-03-18 2015-03-16 4 KIRK RANDAL J by Intrexon Corporation APHB Warrant to Purchase Common Stock P - Purchase I 0.22 3,484,848 3,484,848
2015-03-18 2015-03-16 4 KIRK RANDAL J by Intrexon Corporation APHB Common Stock P - Purchase I 0.1650 13,939,392 2,300 37,939,392
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68,000,000
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68,000,000
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68,000,000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64,000,000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64,000,000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64,000,000
2014-02-18 3 PERRY MICHAEL S APHB Common Stock D 90,000
2014-02-18 3 PERRY MICHAEL S APHB Common Stock D 90,000
2014-02-18 3 COOK JEREMY CURNOCK APHB Common Stock D 130,000
2014-02-18 3 COOK JEREMY CURNOCK APHB Common Stock D 130,000
2008-11-17 3 Robinson BG Susan TGEN Common Stock D 66,915
2007-05-21 2007-05-17 4 BOWMAN JACK L TGEN Common Stock A - Award D 10,000 10,500
2007-05-21 2007-05-17 4 CARTER BARRIE J PHD TGEN Common Stock A - Award D 35,000 48,766
2007-05-21 2007-05-17 4 COOK JEREMY CURNOCK TGEN Common Stock A - Award D 15,000 15,000
2007-05-21 2007-05-17 4 DAVIE JOSEPH MD PHD TGEN Common Stock A - Award D 10,000 11,000
2007-05-21 2007-05-17 4 HAWLEY ROGER TGEN Common Stock A - Award D 10,000 10,000
2007-05-21 2007-05-17 4 LEVY NELSON L TGEN Common Stock A - Award D 10,000 10,070
2007-05-21 2007-05-17 4 PARKER H STEWART TGEN Common Stock A - Award D 50,000 81,175
2007-05-21 2007-05-17 4 PERRY MICHAEL S TGEN Common Stock A - Award D 10,000 10,000
2007-05-21 2007-05-17 4 Poston David J TGEN Common Stock A - Award D 35,000 36,700
2005-11-02 3 PERRY MICHAEL S TGEN Common Stock D 0
2005-10-04 3 Poston David J TGEN Common Stock D 17,000
2005-08-16 3 HAWLEY ROGER TGEN Np securities held D 0
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8700 -2,500 -2 11,926,948
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8600 -25,660 -22 11,929,448
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8500 -11,200 -10 11,955,108
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8300 -10,640 -9 11,966,308
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8200 -12,500 -10 11,976,948
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8100 -2,500 -2 11,989,448
2005-07-27 2005-07-25 4 BIOGEN INC. by Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.7900 -8,500 -7 11,991,948
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 851,873
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 508,673
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 3,060,754
2005-07-12 2003-08-15 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value P - Purchase I 1.9100 2,515,843 4,805 12,127,178
2005-07-12 2002-11-06 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value J - Other I 1.0700 -210,819 -226 9,611,335
2005-07-12 2002-09-30 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value J - Other I 0.5500 104,854 58 9,400,516
2005-01-10 2005-01-06 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7500 -43,600 -76 11,626,282
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7500 -225,335 -394 11,669,882
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7600 -14,465 -25 11,895,217
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.8000 -10,200 -18 11,909,682
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7000 -77,919 -132 11,919,882
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7100 -1,750 -3 11,997,801
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7200 -7,591 -13 11,999,551
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7500 -24,500 -43 12,007,142
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7600 -3,800 -7 12,031,642
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7700 -20,690 -37 12,035,442
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7800 -6,400 -11 12,056,132
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.8000 -1,400 -3 12,062,532
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.8100 -950 -2 12,063,932
2004-04-02 2004-03-31 4 ELAN CORP PLC I TGEN Series B Convertible Exchangeable Preferred Stock C - Conversion I 3.32 -12,015 0
2004-04-02 2004-03-31 4 ELAN CORP PLC I TGEN Common Stock C - Conversion I 3.3200 4,330,000 14,376 12,064,882
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Series B Convertible Exchangeable Preferred Stock J - Other I 3.32 0
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.09 302,934.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.80 63,420.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.88 190,800.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.57 127,200.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.49 134,832.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.65 57,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.83 180,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.96 120,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.19 127,200.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.95 950,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.48 3,000,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3.78 2,000,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3.70 120,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 6.11 2,000,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.09 302,934.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.4900 277,775 136 7,734,882
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.5700 221,757 126 7,457,106
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.6500 87,922 57 7,235,349
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.8300 217,549 181 7,147,427
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.9600 124,630 120 6,929,878
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1.1900 107,044 127 6,805,248
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1.8800 101,439 191 6,698,204
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1.9500 487,248 950 6,596,765
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 2.0900 3,577,879 7,478 6,109,517
2003-11-05 2003-08-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.80 63,420.0000
2003-11-05 2003-06-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.88 190,800.0000
2003-11-05 2003-04-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.57 127,200.0000
2003-11-05 2003-03-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.49 134,832.0000
2003-11-05 2003-02-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.65 57,000.0000
2003-11-05 2002-12-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.83 180,000.0000
2003-11-05 2002-10-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.96 120,000.0000
2003-11-05 2002-09-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.19 127,200.0000
2003-11-05 2002-08-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 1.95 950,000.0000
2003-11-05 2002-06-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 2.48 3,000,000.0000
2003-11-05 2002-04-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 3.78 2,000,000.0000
2003-11-05 2002-03-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3.70 120,000.0000
2003-11-05 2001-09-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 6.11 2,000,000.0000
2003-11-05 2000-08-09 4 ELAN CORP PLC N/A TGEN Common Stock P - Purchase I 13.0640 382,739 5,000 2,531,638
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:TG1N € 6,45
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista